Literature DB >> 19575170

[Peripheral arterial disease: secondary prevention, medical therapy, revascularization].

K-L Schulte1.   

Abstract

Patients with peripheral arterial disease have a high risk of cardiovascular morbidity and mortality. Thus, antiplatelet drugs, antidiabetic, antihypertensive and antilipemic agents should be administered early on. Smoking cessation has to be encouraged and supported. In case of significant reduction of walking distance with impaired quality of life structured and supervised exercise training as well as vasoactive substances have to be offered. If technically feasible and critically discussed with the patient revascularization procedures of the aorto-iliac and the femoro-popliteal segment may be performed. In patients with critical limb ischemia, all options for vascularisation have to be utilized as the main goal is limb salvage. As medication, only prostanoids have to be considered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575170     DOI: 10.1007/s00108-009-2365-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  23 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Influence of smoking on incidence and prevalence of peripheral arterial disease.

Authors:  Edith M Willigendael; Joep A W Teijink; Marie-Louise Bartelink; Barthold W Kuiken; Jelis Boiten; Frans L Moll; Harry R Büller; Martin H Prins
Journal:  J Vasc Surg       Date:  2004-12       Impact factor: 4.268

3.  Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up.

Authors:  Herbert F Lugmayr; Hermann Holzer; Manfred Kastner; Harald Riedelsberger; Alexandra Auterith
Journal:  Radiology       Date:  2002-01       Impact factor: 11.105

4.  Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients.

Authors:  S E Hoeks; W J M Scholte Op Reimer; H van Urk; P J G Jörning; E Boersma; M L Simoons; J J Bax; D Poldermans
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-08-24       Impact factor: 7.069

5.  Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.

Authors:  Martin Schillinger; Schila Sabeti; Christian Loewe; Petra Dick; Jasmin Amighi; Wolfgang Mlekusch; Oliver Schlager; Manfred Cejna; Johannes Lammer; Erich Minar
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

6.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

Authors:  Hans Krankenberg; Michael Schlüter; Hermann J Steinkamp; Karlheinz Bürgelin; Dierk Scheinert; Karl-Ludwig Schulte; Erich Minar; Patrick Peeters; Marc Bosiers; Gunnar Tepe; Bernhard Reimers; Felix Mahler; Thilo Tübler; Thomas Zeller
Journal:  Circulation       Date:  2007-06-25       Impact factor: 29.690

8.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

9.  Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group.

Authors:  E Tetteroo; Y van der Graaf; J L Bosch; A D van Engelen; M G Hunink; B C Eikelboom; W P Mali
Journal:  Lancet       Date:  1998-04-18       Impact factor: 79.321

10.  The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease.

Authors:  R M Greenhalgh; J J F Belch; L C Brown; P A Gaines; L Gao; J A Reise; S G Thompson
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-12       Impact factor: 7.069

View more
  1 in total

1.  [Peripheral arterial disease].

Authors:  C Espinola-Klein
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.